Homology Medicines, Inc. - stock earnings
FIXX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -33.0 million USD | ? USD |
| 2023Q2 | -35.0 million USD | 354000 USD |
| 2023Q1 | -28.8 million USD | 802000 USD |
| 2022Q4 | -32.9 million USD | 802000 USD |
| 2022Q3 | -31.5 million USD | 802000 USD |
| 2022Q2 | -27.7 million USD | 802000 USD |
| 2022Q1 | 92.1 million USD | 802000 USD |
| 2021Q4 | -33.6 million USD | 802000 USD |
| 2021Q3 | -30.6 million USD | 1.7 million USD |
| 2021Q2 | -30.5 million USD | 2.2 million USD |
| 2021Q1 | -1.1 million USD | 29.3 million USD |
| 2020Q4 | -29.8 million USD | 980000 USD |
| 2020Q3 | -28.2 million USD | 567000 USD |
| 2020Q2 | -35.3 million USD | 567000 USD |
| 2020Q1 | -35.3 million USD | 588000 USD |
| 2019Q4 | -24.2 million USD | 563000 USD |
| 2019Q3 | -29.6 million USD | 441000 USD |
| 2019Q2 | -26.3 million USD | 392000 USD |
| 2019Q1 | -23.9 million USD | 270000 USD |
| 2018Q4 | -19.0 million USD | 980002 USD |
| 2018Q3 | -14.8 million USD | 954149 USD |
| 2018Q2 | -12.9 million USD | 926477 USD |
| 2018Q1 | -10.5 million USD | 823372 USD |
| 2017Q4 | -11.9 million USD | ? USD |
| 2017Q3 | -6.5 million USD | ? USD |
| 2017Q2 | -6.0 million USD | ? USD |
| 2017Q1 | -5.6 million USD | ? USD |
| 2016Q4 | -8.0 million USD | ? USD |
FIXX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -131.1 million USD | 2.0 million USD |
| 2022 | 483000 USD | 3.2 million USD |
| 2021 | -95.6 million USD | 34.0 million USD |
| 2020 | -127.1 million USD | 2.7 million USD |
| 2019 | -97.9 million USD | 1.7 million USD |
| 2018 | -57.2 million USD | 3.7 million USD |
| 2017 | -30.0 million USD | ? USD |
| 2016 | -8.0 million USD | ? USD |
FIXX
Price: $0.93
52 week price:
Earnings Per Share: -2.28 USD
P/E Ratio: -0.31
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 53600
Market Capitalization: 51.9 million